Merit Financial Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-26,167
Closed -$160K – 2584
2026
Q2
$160K Buy
26,167
+15,001
+134% +$98K ﹤0.01% 2159
2026
Q1
$77.2K Buy
+11,166
New +$86.1K ﹤0.01% 2035

Other funds holding VNDA

Merit Financial Group's VNDA Position: Q3 2026 in Review

Merit Financial Group sold out of Vanda Pharmaceuticals (VNDA) in Q3 2026, closing a stake of 26,167 shares — an estimated $160K sold.

Merit Financial Group first reported a position in VNDA in Q1 2026 and held it in 2 quarters. The position peaked at $160K in Q2 2026. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • Merit Financial Group reported no remaining Vanda Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Merit Financial Group sold 26,167 Vanda Pharmaceuticals shares in Q3 2026, an estimated $160K.
  • Merit Financial Group first reported a position in Vanda Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • Merit Financial Group's Vanda Pharmaceuticals position peaked at $160K in Q2 2026.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.